Bora Pharmaceuticals Capabilities Update April 2026: Small Molecule Drug Product

Bora Pharmaceuticals is a global CDMO specializing in small molecule drug product development and manufacturing from clinical through commercial supply. Our integrated platform spans oral solids, liquids, semi-solids, nasal sprays, sterile ophthalmics, and sterile injectables, delivering flexible, end-to-end solutions supported by global regulatory expertise.

We leverage advanced technologies such as high-potency handling, modified-release systems, aseptic fill/finish, lyophilization, and controlled substance manufacturing and storage, along with in-house analytical, packaging, and serialization capabilities.

In this presentation, Bora experts will highlight available drug product capacity and our ability to rapidly initiate and scale programs, supported by a strong track record of quality, regulatory success, and reliable and on-time execution.